The effect of chondroitinase on nerve regeneration following composite tissue allotransplantation

Sami Tuffaha, Meghan Quigley, Timothy Ng, Vijay S. Gorantla, Jaimie T. Shores, Benson Pulikkottil, Christopher Shestak, Gerald Brandacher, W. P.Andrew Lee

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Purpose: To improve the degree of functional return and sensibility provided by composite tissue allotransplantation, enhanced nerve regeneration is essential. Chondroitin sulfate proteoglycans are found in the extracellular matrix of nerves and inhibit regenerating axons after injury. Treatment with chondroitinase to remove chondroitin sulfate proteoglycans has been shown to improve nerve regeneration in isolated nerve graft and transection-and-repair models. This study assesses the efficacy of chondroitinase as a neurotherapeutic agent in the setting of composite tissue allotransplantation. Methods: Adult Lewis rats received either orthotopic hind limb transplants from Brown Norway rat donors (n = 12) or sciatic nerve transection and repair (n = 6). Following approximation of the sciatic nerve, half the animals received intraneural injections of chondroitinase in saline and the other half received intraneural injections of saline alone. Five weeks after transplantation, we killed the animals and analyzed nerves with nonbiased quantitative nerve histomorphometry. One day after transection and repair, we killed animals and harvested sciatic nerves for immunohistochemical staining of cleaved chondroitin sulfate proteoglycans epitope and laminin. We used unpaired t-tests for statistical analysis. Results: Distal to the suture line, chondroitinase-treated animals demonstrated statistically greater total number of fibers and nerve density compared with controls. There were no statistically significant differences in fiber number or nerve density proximal to the suture line or in fiber widths. We observed staining of cleaved chondroitin sulfate proteoglycan epitopes only in treated animals, with no differences observed in the degree of laminin staining. Conclusions: Intraneural injection of chondroitinase cleaved inhibitory chondroitin sulfate proteoglycans without disrupting proregenerative laminin and resulted in enhanced nerve regeneration after composite tissue allotransplantation. Studies at later time points are needed to assess whether this enhanced nerve regeneration will produce improved functional return. Clinical relevance: This study identifies a promising therapeutic agent that has the potential to enhance nerve regeneration and functional outcomes for patients undergoing composite tissue allotransplantation.

Original languageEnglish (US)
Pages (from-to)1447-1452
Number of pages6
JournalJournal of Hand Surgery
Volume36
Issue number9
DOIs
StatePublished - Sep 1 2011
Externally publishedYes

Fingerprint

Vascularized Composite Allotransplantation
Chondroitinases and Chondroitin Lyases
Chondroitin Sulfate Proteoglycans
Nerve Regeneration
Laminin
Sciatic Nerve
Staining and Labeling
Sutures
Injections
Epitopes
Transplants
Nerve Fibers
Extracellular Matrix
Axons
Extremities
Transplantation
Tissue Donors
Wounds and Injuries
Therapeutics

Keywords

  • Chondroitinase
  • nerve
  • regeneration
  • transplantation

ASJC Scopus subject areas

  • Surgery
  • Orthopedics and Sports Medicine

Cite this

The effect of chondroitinase on nerve regeneration following composite tissue allotransplantation. / Tuffaha, Sami; Quigley, Meghan; Ng, Timothy; Gorantla, Vijay S.; Shores, Jaimie T.; Pulikkottil, Benson; Shestak, Christopher; Brandacher, Gerald; Lee, W. P.Andrew.

In: Journal of Hand Surgery, Vol. 36, No. 9, 01.09.2011, p. 1447-1452.

Research output: Contribution to journalArticle

Tuffaha, S, Quigley, M, Ng, T, Gorantla, VS, Shores, JT, Pulikkottil, B, Shestak, C, Brandacher, G & Lee, WPA 2011, 'The effect of chondroitinase on nerve regeneration following composite tissue allotransplantation', Journal of Hand Surgery, vol. 36, no. 9, pp. 1447-1452. https://doi.org/10.1016/j.jhsa.2011.06.007
Tuffaha, Sami ; Quigley, Meghan ; Ng, Timothy ; Gorantla, Vijay S. ; Shores, Jaimie T. ; Pulikkottil, Benson ; Shestak, Christopher ; Brandacher, Gerald ; Lee, W. P.Andrew. / The effect of chondroitinase on nerve regeneration following composite tissue allotransplantation. In: Journal of Hand Surgery. 2011 ; Vol. 36, No. 9. pp. 1447-1452.
@article{5492ac20478e418c841de0ae37ce3c79,
title = "The effect of chondroitinase on nerve regeneration following composite tissue allotransplantation",
abstract = "Purpose: To improve the degree of functional return and sensibility provided by composite tissue allotransplantation, enhanced nerve regeneration is essential. Chondroitin sulfate proteoglycans are found in the extracellular matrix of nerves and inhibit regenerating axons after injury. Treatment with chondroitinase to remove chondroitin sulfate proteoglycans has been shown to improve nerve regeneration in isolated nerve graft and transection-and-repair models. This study assesses the efficacy of chondroitinase as a neurotherapeutic agent in the setting of composite tissue allotransplantation. Methods: Adult Lewis rats received either orthotopic hind limb transplants from Brown Norway rat donors (n = 12) or sciatic nerve transection and repair (n = 6). Following approximation of the sciatic nerve, half the animals received intraneural injections of chondroitinase in saline and the other half received intraneural injections of saline alone. Five weeks after transplantation, we killed the animals and analyzed nerves with nonbiased quantitative nerve histomorphometry. One day after transection and repair, we killed animals and harvested sciatic nerves for immunohistochemical staining of cleaved chondroitin sulfate proteoglycans epitope and laminin. We used unpaired t-tests for statistical analysis. Results: Distal to the suture line, chondroitinase-treated animals demonstrated statistically greater total number of fibers and nerve density compared with controls. There were no statistically significant differences in fiber number or nerve density proximal to the suture line or in fiber widths. We observed staining of cleaved chondroitin sulfate proteoglycan epitopes only in treated animals, with no differences observed in the degree of laminin staining. Conclusions: Intraneural injection of chondroitinase cleaved inhibitory chondroitin sulfate proteoglycans without disrupting proregenerative laminin and resulted in enhanced nerve regeneration after composite tissue allotransplantation. Studies at later time points are needed to assess whether this enhanced nerve regeneration will produce improved functional return. Clinical relevance: This study identifies a promising therapeutic agent that has the potential to enhance nerve regeneration and functional outcomes for patients undergoing composite tissue allotransplantation.",
keywords = "Chondroitinase, nerve, regeneration, transplantation",
author = "Sami Tuffaha and Meghan Quigley and Timothy Ng and Gorantla, {Vijay S.} and Shores, {Jaimie T.} and Benson Pulikkottil and Christopher Shestak and Gerald Brandacher and Lee, {W. P.Andrew}",
year = "2011",
month = "9",
day = "1",
doi = "10.1016/j.jhsa.2011.06.007",
language = "English (US)",
volume = "36",
pages = "1447--1452",
journal = "Journal of Hand Surgery",
issn = "0363-5023",
publisher = "W.B. Saunders Ltd",
number = "9",

}

TY - JOUR

T1 - The effect of chondroitinase on nerve regeneration following composite tissue allotransplantation

AU - Tuffaha, Sami

AU - Quigley, Meghan

AU - Ng, Timothy

AU - Gorantla, Vijay S.

AU - Shores, Jaimie T.

AU - Pulikkottil, Benson

AU - Shestak, Christopher

AU - Brandacher, Gerald

AU - Lee, W. P.Andrew

PY - 2011/9/1

Y1 - 2011/9/1

N2 - Purpose: To improve the degree of functional return and sensibility provided by composite tissue allotransplantation, enhanced nerve regeneration is essential. Chondroitin sulfate proteoglycans are found in the extracellular matrix of nerves and inhibit regenerating axons after injury. Treatment with chondroitinase to remove chondroitin sulfate proteoglycans has been shown to improve nerve regeneration in isolated nerve graft and transection-and-repair models. This study assesses the efficacy of chondroitinase as a neurotherapeutic agent in the setting of composite tissue allotransplantation. Methods: Adult Lewis rats received either orthotopic hind limb transplants from Brown Norway rat donors (n = 12) or sciatic nerve transection and repair (n = 6). Following approximation of the sciatic nerve, half the animals received intraneural injections of chondroitinase in saline and the other half received intraneural injections of saline alone. Five weeks after transplantation, we killed the animals and analyzed nerves with nonbiased quantitative nerve histomorphometry. One day after transection and repair, we killed animals and harvested sciatic nerves for immunohistochemical staining of cleaved chondroitin sulfate proteoglycans epitope and laminin. We used unpaired t-tests for statistical analysis. Results: Distal to the suture line, chondroitinase-treated animals demonstrated statistically greater total number of fibers and nerve density compared with controls. There were no statistically significant differences in fiber number or nerve density proximal to the suture line or in fiber widths. We observed staining of cleaved chondroitin sulfate proteoglycan epitopes only in treated animals, with no differences observed in the degree of laminin staining. Conclusions: Intraneural injection of chondroitinase cleaved inhibitory chondroitin sulfate proteoglycans without disrupting proregenerative laminin and resulted in enhanced nerve regeneration after composite tissue allotransplantation. Studies at later time points are needed to assess whether this enhanced nerve regeneration will produce improved functional return. Clinical relevance: This study identifies a promising therapeutic agent that has the potential to enhance nerve regeneration and functional outcomes for patients undergoing composite tissue allotransplantation.

AB - Purpose: To improve the degree of functional return and sensibility provided by composite tissue allotransplantation, enhanced nerve regeneration is essential. Chondroitin sulfate proteoglycans are found in the extracellular matrix of nerves and inhibit regenerating axons after injury. Treatment with chondroitinase to remove chondroitin sulfate proteoglycans has been shown to improve nerve regeneration in isolated nerve graft and transection-and-repair models. This study assesses the efficacy of chondroitinase as a neurotherapeutic agent in the setting of composite tissue allotransplantation. Methods: Adult Lewis rats received either orthotopic hind limb transplants from Brown Norway rat donors (n = 12) or sciatic nerve transection and repair (n = 6). Following approximation of the sciatic nerve, half the animals received intraneural injections of chondroitinase in saline and the other half received intraneural injections of saline alone. Five weeks after transplantation, we killed the animals and analyzed nerves with nonbiased quantitative nerve histomorphometry. One day after transection and repair, we killed animals and harvested sciatic nerves for immunohistochemical staining of cleaved chondroitin sulfate proteoglycans epitope and laminin. We used unpaired t-tests for statistical analysis. Results: Distal to the suture line, chondroitinase-treated animals demonstrated statistically greater total number of fibers and nerve density compared with controls. There were no statistically significant differences in fiber number or nerve density proximal to the suture line or in fiber widths. We observed staining of cleaved chondroitin sulfate proteoglycan epitopes only in treated animals, with no differences observed in the degree of laminin staining. Conclusions: Intraneural injection of chondroitinase cleaved inhibitory chondroitin sulfate proteoglycans without disrupting proregenerative laminin and resulted in enhanced nerve regeneration after composite tissue allotransplantation. Studies at later time points are needed to assess whether this enhanced nerve regeneration will produce improved functional return. Clinical relevance: This study identifies a promising therapeutic agent that has the potential to enhance nerve regeneration and functional outcomes for patients undergoing composite tissue allotransplantation.

KW - Chondroitinase

KW - nerve

KW - regeneration

KW - transplantation

UR - http://www.scopus.com/inward/record.url?scp=80052271907&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052271907&partnerID=8YFLogxK

U2 - 10.1016/j.jhsa.2011.06.007

DO - 10.1016/j.jhsa.2011.06.007

M3 - Article

C2 - 21788107

AN - SCOPUS:80052271907

VL - 36

SP - 1447

EP - 1452

JO - Journal of Hand Surgery

JF - Journal of Hand Surgery

SN - 0363-5023

IS - 9

ER -